Assessing the treatment adherence and clinical correlates of low adherence among bipolar disorder outpatients: a cross-sectional study

References

• Karanti A, Kardell M, Lundberg U, et al. Changes in mood stabilizer prescription patterns in bipolar disorder. J Affect Disord. 2016;195:50–56. doi: 10.1016/j.jad.2016.01.043
   PubMed Web of Science ®Google Scholar
• Kessing LV, Vradi E, Andersen PK. Nationwide and population-based prescription patterns in bipolar disorder. Bipolar Disord. 2016;18(2):174–182. doi: 10.1111/bdi.12371
   PubMed Web of Science ®Google Scholar
• Vieta E, Azorin JM, Bauer M, et al. Psychiatrists’ perceptions of potential reasons for non- and partial adherence to medication: results of a survey in bipolar disorder from eight European countries. J Affect Disord. 2012;143:125–130. doi: 10.1016/j.jad.2012.05.041
   PubMed Web of Science ®Google Scholar
• Chang CW, Sajatovic M, Tatsuoka C. Correlates of attitudes towards mood stabilizers in individuals with bipolar disorder. Bipolar Disord. 2015;17:106–112. doi: 10.1111/bdi.12226
   Web of Science ®Google Scholar
• Jónsdóttir H, Opjordsmoen S, Birkenaes AB, et al. Predictors of medication adherence in patients with schizophrenia and bipolar disorder. Acta Psychiatr Scand. 2013;127:23–33. doi: 10.1111/j.1600-0447.2012.01911.x
   PubMed Web of Science ®Google Scholar
• Sabate E. Adherence to long term therapies: evidence for action. Geneva: World Health Organization; 2003.
   Google Scholar
• Balikci A, Erdem M, Zincir S, et al. Adherence with outpatient appointments and medication: a two-year prospective study of patients with Schizophrenia. Bull Clin Psychopharmacol. 2013;23(1):57–64. doi: 10.5455/bcp.20121130085931
   Google Scholar
• Higashi K, Medic G, Littlewood KJ, et al. Medication adherence in Schizophrenia: factors influencing adherence and consequences of non-adherence, a systematic literature review. Ther Adv Psychopharmacol. 2013;3(4):200–218. doi: 10.1177/2045125312474019
   PubMedGoogle Scholar
• Najimi A, Mostafavi F, Sharifirad G, et al. Barriers to medication adherence in patients with hypertension: a qualitative study. J Educ Health Promot. 2018;9:7–24.
   Google Scholar
• Zeber JE, Copeland LA, Good CB, et al. Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder. J Affect Disord. 2008;107:53–62. doi: 10.1016/j.jad.2007.07.026
   PubMed Web of Science ®Google Scholar
• Sajatovic M, DiBiasi F, Legacy SN. Attitudes toward antipsychotic treatment among patients with bipolar disorders and their clinicians: a systematic review. Neuropsychiatr Dis Treat. 2017;13:2285–2296. doi: 10.2147/NDT.S139557
   PubMed Web of Science ®Google Scholar
• Altınbas K, Smith D, Oral ET. Adherence to Turkish psychiatric association guideline for bipolar depression treatment in a specialized mood disorders outpatient unit. Psychiatr Danub. 2011;23(2):189–193.
   PubMed Web of Science ®Google Scholar
• Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry. 2002;63(5):384–390. doi: 10.4088/JCP.v63n0502
   PubMed Web of Science ®Google Scholar
• Deniz S, Sancar M, Okuyan B, et al. Determination of CYP2C19 polymorphism, side effects, and medication adherence in patients who have utilized selective serotonin reuptake inhibitors. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 2016;26(2):152–160. doi: 10.5455/bcp.20151003060610
   Web of Science ®Google Scholar
• Berk L, Hallam KT, Colom F, et al. Enhancing medication adherence in patients with bipolar disorder. Hum Psychopharmacol. 2010;25(1):1–16. doi: 10.1002/hup.1081
   PubMed Web of Science ®Google Scholar
• Mert DG, Turgut NH, Kelleci M, et al. Perspectives on reasons of medication nonadherence in psychiatric patients. Patient Prefer Adherence. 2015;9:87–93. doi: 10.2147/PPA.S75013
   PubMed Web of Science ®Google Scholar
• Lama S, Lakshmi K, Shyangwa P, et al. Level of compliance and factors associated with non-compliance to treatment among the mentally ill patients. Health Renaissance. 2012;10:113–117. doi: 10.3126/hren.v10i2.6577
   Google Scholar
• Cetin M, Aricioglu F, Acikel CH, et al. Today’s psychopharmacological treatments: results, problems, new perspectives. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 2012;22(2):198–204. doi: 10.5455/bcp.20120702032135
   Web of Science ®Google Scholar
• Levin JB, Krivenko A, Howland M, et al. Medication adherence in patients with bipolar disorder: a comprehensive review. CNS Drugs. 2016;30(9):819–835. doi: 10.1007/s40263-016-0368-x
   PubMed Web of Science ®Google Scholar
• Miasso AI, do Carmo BP, Tirapelli CR. Bipolar affective disorder: pharmacotherapeutic profile and adherence to medication. Rev Esc Enferm USP. 2012;46:689–695. doi: 10.1590/S0080-62342012000300022
   Web of Science ®Google Scholar
• Leclerc E, Mansur RB, Brietzke E. Determinants of adherence to treatment in bipolar disorder: a comprehensive review. J Affect Disord. 2013;149(1–3):247–252. doi: 10.1016/j.jad.2013.01.036
   PubMed Web of Science ®Google Scholar
• Col SE, Caykoylu A, Karakas Ugurlu G, et al. Factors affecting treatment compliance in patients with bipolar I disorder during prophylaxis: a study from Turkey. Gen Hosp Psychiatry. 2014;36(2):208–213. doi: 10.1016/j.genhosppsych.2013.11.006
   Web of Science ®Google Scholar
• Cakir S, Bensusan R, Akca ZK, et al. Does a psychoeducational approach reach targeted patients with bipolar disorder? J Affect Disord. 2009;119(1–3):190–193. doi: 10.1016/j.jad.2009.08.016
   Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Washington (DC): American Psychiatric Association; 2000.
   Google Scholar
• Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–435. doi: 10.1192/bjp.133.5.429
   PubMed Web of Science ®Google Scholar
• Hamilton M. A raiting scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62. doi: 10.1136/jnnp.23.1.56
   PubMed Web of Science ®Google Scholar
• Guy W. ECDU assessment manual for psychopharmacology, revised. Bethesda (MD): US Department of Health, Education and Welfare; 1976.
   Google Scholar
• First MB, Spitzer RL, Gibbon M, et al. Structered Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID/CV). Washington (DC): American Psychiatric Pres, Inc; 1997.
   Google Scholar
• Corapçıoglu A, Aydemir Ö, Yıldız M, et al. DSM-IV Eksen I Bozuklukları (SCID-I) İçin Yapılandırılmış Klinik Görüşme, Klinik Versiyon. Ankara: Hekimler Yayın Birliği; 1999; [Turkish].
   Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–354. doi: 10.1111/j.1751-7176.2008.07572.x
   PubMed Web of Science ®Google Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74. doi: 10.1097/00005650-198601000-00007
   PubMed Web of Science ®Google Scholar
• Gray R, Leese M, Bindman J, et al. Adherence therapy for people with schizophrenia. Br J Psychiatry. 2006;189:508–514. doi: 10.1192/bjp.bp.105.019489
   PubMed Web of Science ®Google Scholar
• Hacıhasanoğlu-Asılar R, Gözüm S, Capik C, et al. Reliability and validity of the Turkish form of the eight-item Morisky medication adherence scale in hypertensive patients. Anadolu Kardiyol Derg. 2014;14(8):692–700. [Turkish]. doi: 10.5152/akd.2014.4982
   Google Scholar
• Karadag F, Oral ET, Aran-Yalçın F, et al. Young Mani Derecelendirme Ölçeğinin Türkiye’de Geçerlik ve Güvenilirliği. Turk Psikiyatri Derg. 2001;13(2):107–114. [Turkish].
   Google Scholar
• Akdemir A, Örsel S, Dağ İ, et al. Hamilton Depresyon Derecelendirme Ölçeği (HDDÖ)’nin geçerliği, güvenirliği ve klinikte kullanımı. 3P Dergisi. 1996;4(4):251–259. [Turkish].
   Google Scholar
• David A, Buchanan A, Reed A. Assessment of insight in psychosis. Br J Psychiatry. 1992;161:599–602. doi: 10.1192/bjp.161.5.599
   PubMed Web of Science ®Google Scholar
• Arslan S, Gunay-Kılıc B, Karakılıc H. İçgörünün Üç Bileşenini Değerlendirme ölçeği güvenirlik ve geçerlik çalışması. Türkiye’de Psikiyatri. 2000;3:17–24. [Turkish].
   Google Scholar
• Endicott J, Spitzer RL, Fleiss JL, et al. The global assessment scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33(6):766–771. doi: 10.1001/archpsyc.1976.01770060086012
   PubMed Web of Science ®Google Scholar
• Montes JM, Maurino J, de Dios C, et al. Suboptimal treatment adherence in bipolar disorder: impact on clinical outcomes and functioning. Patient Prefer Adherence. 2013;7:89–94.
   PubMed Web of Science ®Google Scholar
• Chakrabarti S. What’s in a name? Compliance, adherence and concordance in chronic psychiatric disorders. World J Psychiatry. 2014;4:30–36. doi: 10.5498/wjp.v4.i2.30
   PubMedGoogle Scholar
• Perlis RH, Ostacher MJ, Miklowitz DJ, et al. Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP­BD study. J Clin Psychiatry. 2010;71:296–303. doi: 10.4088/JCP.09m05514yel
   PubMed Web of Science ®Google Scholar
• Kim SW, Berk L, Kulkarni J, et al. Impact of comorbid anxiety disorders and obsessive-compulsive disorder on 24-month clinical outcomes of bipolar I disorder. J Affect Disord. 2014;166:243–248. doi: 10.1016/j.jad.2014.05.017
   Web of Science ®Google Scholar
• Buturak SV, Emel EB, Koçak OM. The effect of temperament on the treatment adherence of bipolar disorder type I. Nord J Psychiatry. 2016;70(3):176–182. doi: 10.3109/08039488.2015.1067330
   PubMed Web of Science ®Google Scholar
• Arvilommi P, Suominen K, Mantere O, et al. Predictors of adherence to psychopharmacological and psychosocial treatment in bipolar I or II disorders – an 18-month prospective study. J Affect Disord. 2014;155:110–117. doi: 10.1016/j.jad.2013.10.032
   PubMed Web of Science ®Google Scholar
• Martínez-Arán A, Scott J, Colom F, et al. Treatment nonadherence and neurocognitive impairment in bipolar disorder. J Clin Psychiatry. 2009;70:1017–1023. doi: 10.4088/JCP.08m04408
   PubMed Web of Science ®Google Scholar
• Corréard N, Consoloni JL, Raust A, et al. Neuropsychological functioning, age, and medication adherence in bipolar disorder. PLoS ONE. 2017;12(9):e0184313.47. doi: 10.1371/journal.pone.0184313
   Web of Science ®Google Scholar
• Navarro S, Rodríguez F, Acosta FJ, et al. Variables associated with nonadherence in clinically stable patients with bipolar disorder. Actas Esp Psiquiatr. 2016;44(5):157–165.
   Web of Science ®Google Scholar
• Baldessarini RJ, Perry R, Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum Psychopharmacol. 2008;23:95–105. doi: 10.1002/hup.908
   PubMed Web of Science ®Google Scholar
• Subramanian K, Sarkar S, Kattimani S. Bipolar disorder in Asia: illness course and contributing factors. Asian J Psychiatr. 2017;29:16–29. doi: 10.1016/j.ajp.2017.04.009
   PubMed Web of Science ®Google Scholar
• Da Silva RDA, Mograbi DC, Silveira LAS, et al. Insight across the different mood states of bipolar disorder. Psychiatr Q. 2015;86:395–405. doi: 10.1007/s11126-015-9340-z
   Web of Science ®Google Scholar
• Clatworthy J, Bowskill R, Parham R, et al. Understanding medication non­adherence in bipolar disorders using a Necessity­Concerns Framework. J Affect Disord. 2009;116:51–55. doi: 10.1016/j.jad.2008.11.004
   PubMed Web of Science ®Google Scholar
• Depp CA, Moore DJ, Patterson TL, et al. Psychosocial interventions and medication adherence in bipolar disorder. Dialogues Clin Neurosci. 2008;10:239–250.
   PubMedGoogle Scholar
• Eker F, Harkın S. Effectiveness of six-week psychoeducation program on adherence of patients with bipolar affective disorder. J Affect Disord. 2012;138:409–416. doi: 10.1016/j.jad.2012.01.004
   Web of Science ®Google Scholar